Ghamlouche, F.; Yehya, A.; Kurdi, A.; Hachem, S.; Prabhu, V.V.; Daoud, G.; Abou-Kheir, W.
Integrated Phenotypic and Transcriptomic Profiling Positions ONC212 as a Lead Imipridone in Androgen-Independent Prostate Cancer Models. Int. J. Mol. Sci. 2026, 27, 4597.
https://doi.org/10.3390/ijms27104597
AMA Style
Ghamlouche F, Yehya A, Kurdi A, Hachem S, Prabhu VV, Daoud G, Abou-Kheir W.
Integrated Phenotypic and Transcriptomic Profiling Positions ONC212 as a Lead Imipridone in Androgen-Independent Prostate Cancer Models. International Journal of Molecular Sciences. 2026; 27(10):4597.
https://doi.org/10.3390/ijms27104597
Chicago/Turabian Style
Ghamlouche, Fatima, Amani Yehya, Abdallah Kurdi, Sana Hachem, Varun V. Prabhu, Georges Daoud, and Wassim Abou-Kheir.
2026. "Integrated Phenotypic and Transcriptomic Profiling Positions ONC212 as a Lead Imipridone in Androgen-Independent Prostate Cancer Models" International Journal of Molecular Sciences 27, no. 10: 4597.
https://doi.org/10.3390/ijms27104597
APA Style
Ghamlouche, F., Yehya, A., Kurdi, A., Hachem, S., Prabhu, V. V., Daoud, G., & Abou-Kheir, W.
(2026). Integrated Phenotypic and Transcriptomic Profiling Positions ONC212 as a Lead Imipridone in Androgen-Independent Prostate Cancer Models. International Journal of Molecular Sciences, 27(10), 4597.
https://doi.org/10.3390/ijms27104597